Early Angiotensin Converting Enzyme Inhibition in Patients after Myocardial Infarction
Cardiovascular Protective Effects of Angiotensin Converting Enzyme Inhibitors
Current Trends and Future Prospects in the Pharmacologic Management of Hypertension
Do All Patients Deserve Treatment with Angiotensin Converting Enzyme Inhibitors after Myocardial Infarction? An Argument to Treat only High-Risk Patients